Table 1 Profiles of patients from which mucosal biopsies were collected.

From: Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease

Pt #

Symptoms

Medication

Pathology

Endoscopy

1

none

none

normal tissue

none

2

none

none

normal tissue

none

3

none

none

normal tissue

none

4

none

none

normal tissue

none

5

flare-up, 15–20 bm/d

Steroids, biologic

chronic inflammation, severe activity

pancolitis, Mayo 3 distal, 2 proximal

6

flare-up, 10 bm/d

none

chronic inflammation, moderate to severe activity

pancolitis, Mayo 2

7

chronic active, 4 bm/d

none

chronic inflammation, mild activity

proctitis, Mayo 1

8

chronic active, 2–3 bm/d

5-ASA

chronic inflammation, marked activity

pancolitis, Mayo 3 distal, 2 proximal

9

new onset, 6–8 bm/d

none

chronic inflammation, moderate activity

pancolitis, Mayo 2

10

chronic active, 12 bm/d*

Steroid enema, 5-ASA

chronic inflammation, mild activity

proctitis, Mayo 2

11

flare-up, 6–8 bm/d

Imuran

acute, chronic inflammation, deep ulcers

ileocolitis, deep ulcers

12

flare-up, 4–5 bm/d

5-ASA

chronic inflammation, severe activity

colitis

13

flare-up, pain, +2 bm/d

5-ASA

normal tissue; chronic stricture with no active inflammation

ileal stricture, blind biopsies

14

flare-up, 2–5 bm/day

none

chronic inflammation, moderate activity

pancolitis, Mayo 1–2

  1. 5-ASA = 5 aminosalicylic acid; *mucous, but infrequent stool; **suspected flare up initially but with further imaging dx. with chronic stricture with no active inflammation; bm = bowel movement, most were bloody.